| 2401 |
|
Rituximab for the treatment of refractory autoimmune hemolytic anemia in children/
|
Zecca, M
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2402 |
|
Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial/
|
Ekstrand, B. C
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2403 |
|
Rituximab in relapsed or refractory hairy cell leukemia/
|
Thomas, D. A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2404 |
|
Rituximab in the very young: benefits in AIHA, at what risk?/
|
Matthews, D. C
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2405 |
|
Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)/
|
Mounier, N
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2406 |
|
RNAi meets imatinib mesylate/
|
Eder, M
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2407 |
|
Role of AP1/NFE2 binding sites in endogenous alpha-globin gene transcription/
|
Loyd, M. R
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2408 |
|
Role of deferiprone in chelation therapy for transfusional iron overload/
|
Hoffbrand, A. V
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2409 |
|
Role of macrophages in the generation of circulating blood nucleosomes from dead and dying cells/
|
Jiang, N
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2410 |
|
Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow cytometry-based novel culture system/
|
Zhang, J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2411 |
|
Role of the intracellular domains of GPIb in controlling the adhesive properties of the platelet GPIb/V/IX complex/
|
Perrault, C
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2412 |
|
Roles of neutrophil beta2 integrins in kinetics of bacteremia, extravasation, and tick acquisition of Anaplasma phagocytophila in mice/
|
Borjesson, D. L
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2413 |
|
Rosmarinic acid inhibits Ca^2^+-dependent pathways of T-cell antigen receptor-mediated signaling by inhibiting the PLC-gamma1 and Itk activity/
|
Kang, M.-A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2414 |
|
RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation/
|
Elagib, K. E
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2415 |
|
RUNX/AML and C/EBP factors regulate CD11a integrin expression in myeloid cells through overlapping regulatory elements/
|
Puig-Kroger, A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2416 |
|
Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone/
|
Cohen, A. R
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2417 |
|
Secondary leukemia or unfavorable leukemia?/
|
Rowe, J. M
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2418 |
|
Selective blockade of CD28 and not CTLA-4 with a single-chain Fv-alpha~1-antitrypsin fusion antibody/
|
Vanhove, B
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2419 |
|
Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses/
|
Amrolia, P. J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2420 |
|
Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis/
|
Yao, L
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|